Work

Pazopanib plus cetuximab in recurrent or metastatic head and neck squamous cell carcinoma: an open-label, phase 1b and expansion study

Year: 2018

Type: article

Study design: Clinical Trial

Source: The Lancet Oncology

DOI: 10.1016/s1470-2045(18)30350-4

Authors: Douglas Adkins, Paul Mehan, Jessica Ley, Marilyn J Siegel, Barry A Siegel, Farrokh Dehdashti, Xuntian Jiang, Noha N Salama, Kathryn Trinkaus, Peter Oppelt

Institutions: Washington University in St. Louis, Alvin J. Siteman Cancer Center, Cairo University, University of Health Sciences and Pharmacy

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: GlaxoSmithKline, Novartis Pharmaceuticals Corporation, Alvin J. Siteman Cancer Center, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G12431752, G2337220457, G681711226, Cancer Center Support Grant

OpenAlex ID: W2835940100

FWCI: 1.815

Cites: 31

Cited by: 28

Related to: 10